'Living drug' offers hope to terminal blood cancer patients NHS patients with lymphoma have for the first time been given a pioneering treatment that genetically reprogrammes their immune system to fight cancer.
Mike Simpson, 62, from Durham, says his cancer is now "on the run".
The therapy, called CAR-T, is a "living drug" that is tailor-made for each patient using their body's own cells
Doctors at King's College Hospital, London, said some patients were being completely cured in a way that had "never been seen before". BBC News
No comments:
Post a Comment